195 related articles for article (PubMed ID: 15853560)
1. Paroxetine in panic disorder: clinical management and long-term follow-up.
Dannon PN; Lowengrub K; Iancu I; Kotler M
Expert Rev Neurother; 2004 Mar; 4(2):191-8. PubMed ID: 15853560
[TBL] [Abstract][Full Text] [Related]
2. Treatment of panic disorder: focus on paroxetine.
Pollack MH; Doyle AC
Psychopharmacol Bull; 2003; 37 Suppl 1():53-63. PubMed ID: 14566201
[TBL] [Abstract][Full Text] [Related]
3. The long-term treatment of panic disorder.
Davidson JR
J Clin Psychiatry; 1998; 59 Suppl 8():17-21; discussion 22-3. PubMed ID: 9707158
[TBL] [Abstract][Full Text] [Related]
4. Comorbid cannabis use and panic disorder: short term and long term follow-up study.
Dannon PN; Lowengrub K; Amiaz R; Grunhaus L; Kotler M
Hum Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 14994319
[TBL] [Abstract][Full Text] [Related]
5. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacotherapy of panic disorder].
Bougerol T; Farisse J
Encephale; 1996 Dec; 22 Spec No 5():46-53. PubMed ID: 9138947
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine: a review of clinical experience.
Dunner D; Kumar R
Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236
[TBL] [Abstract][Full Text] [Related]
8. [Clinical effect and tolerance of paxil (paroxetine) in management of panic disorders].
Mosolov SN; Smulevich AB; Nuller IuL; Grigor'evskikh VS; Kostiukova EG; Kuzavkova MV; Koliutskaia EV; Andriushchenko AV; Zelenina EV; Kosinskiĭ VP; Kozlovskiĭ VL; Bykov SI; Pererva IG
Ter Arkh; 2000; 72(10):16-23. PubMed ID: 11220870
[TBL] [Abstract][Full Text] [Related]
9. Antidepressants in panic disorder.
Wade AG
Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S13-7. PubMed ID: 10471168
[TBL] [Abstract][Full Text] [Related]
10. Three year naturalistic outcome study of panic disorder patients treated with paroxetine.
Dannon PN; Iancu I; Cohen A; Lowengrub K; Grunhaus L; Kotler M
BMC Psychiatry; 2004 Jun; 4():16. PubMed ID: 15191617
[TBL] [Abstract][Full Text] [Related]
11. Efficacy studies of paroxetine in panic disorder.
Lydiard RB; Steiner M; Burnham D; Gergel I
Psychopharmacol Bull; 1998; 34(2):175-82. PubMed ID: 9640997
[TBL] [Abstract][Full Text] [Related]
12. Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study.
Marchesi C; De Panfilis C; Cantoni A; Fontò S; Giannelli MR; Maggini C
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1240-5. PubMed ID: 16678956
[TBL] [Abstract][Full Text] [Related]
13. Nocturnal sleep panic and depression: relationship to subjective sleep in panic disorder.
Singareddy R; Uhde TW
J Affect Disord; 2009 Jan; 112(1-3):262-6. PubMed ID: 18558437
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram in the treatment of generalized anxiety disorder.
Baldwin DS; Nair RV
Expert Rev Neurother; 2005 Jul; 5(4):443-9. PubMed ID: 16026227
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
Faludi G; Tekes K; Tóthfalusi L
J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
[TBL] [Abstract][Full Text] [Related]
16. Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants?
Dusseldorp E; Spinhoven P; Bakker A; van Dyck R; van Balkom AJ
Psychother Psychosom; 2007; 76(3):154-61. PubMed ID: 17426414
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
Kamijima K; Aoki M
Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
[TBL] [Abstract][Full Text] [Related]
18. Identifying and treating panic disorder in primary care.
Culpepper L
J Clin Psychiatry; 2004; 65 Suppl 5():19-23. PubMed ID: 15078114
[TBL] [Abstract][Full Text] [Related]
19. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.
Bhanji NH; Chouinard G; Kolivakis T; Margolese HC
Can J Clin Pharmacol; 2006; 13(1):e69-74. PubMed ID: 16456219
[TBL] [Abstract][Full Text] [Related]
20. Panic disorder and suicidality: is comorbidity with depression the key?
Diaconu G; Turecki G
J Affect Disord; 2007 Dec; 104(1-3):203-9. PubMed ID: 17442399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
